Unlocking the Power of Pancreatic Nerves
The pancreas plays a vital role in managing blood sugar by producing insulin, a hormone necessary for glucose regulation. In type 1 diabetes (T1D), the body’s immune system mistakenly attacks insulin-producing beta cells, severely impairing insulin production. Recent research highlights a key aspect of pancreatic function often overlooked: the role of the nervous system in supporting the health and function of these cells.
The DRI proposes to explore how pancreatic nerves can help maintain and improve insulin-producing cell function, or, conversely, how dysfunctional nerve signaling could trigger their destruction. We aim to create a treatment that not only supports cell health but holds potential to curb T1D at its core. This research could pave the way for novel therapies that enhance pancreatic function and offer long-term solutions to T1D.
Our goal is ambitious: harnessing the body’s natural signaling pathways to improve and possibly restore the health of insulin-producing cells. The project’s success hinges on advancing our understanding of the pancreas and nervous system interaction and developing devices to harness these signals for therapeutic benefit. Such a project requires comprehensive research, advanced models, and cutting-edge technology – all of which demand substantial resources.
By funding this initiative, you would contribute to a novel approach, with the potential to transform T1D therapy from management to cure. Together, we can advance a paradigm-shifting intervention that could redefine diabetes treatment and enable a diabetes-free future.
Utilizing Immune Evasion Molecules
T1D results from the destruction of insulin-producing beta cells in pancreatic islets by cells of the immune system. However, it is known that some beta cells can evade this immune attack. Residual dormant beta cells can be found “hibernating” in patients who have had T1D for several decades, however exactly **how **these beta cells evade immune attack is currently a mystery. Experiments which uncover key immune evasion molecules that protect beta cells during immune cell attack could lead us directly to the design of specific therapeutic strategies to cure T1D. Developing a platform to test potential therapeutics in a systematic/high-throughput manner, could revolutionize and fast-track the path to a cure.
Most therapeutic strategies for treating T1D have focused on the immune system rather than the beta cells themselves. We believe that with your help we can find a way to ensure that beta cells evade immune attack, which could hold the key to effective and durable treatment success for patients with T1D. At DRI, our dedication to innovative non-clinical studies marks a critical step on the path from bench to bedside. Our expertise and links with vital stakeholders place us in the perfect position to develop such cellular platforms. The DRI’s clinical core is specifically designed to support and monitor trials for patients with diabetes. We have the expertise, facilities and tools in place to revolutionize the treatment of T1D, but we need financial support to help us achieve our ultimate goal of curative treatments for patients with diabetes.
The Diabetes Research Institute (DRI) leads the world in cure-focused diabetes research. As one of the nation’s largest and most comprehensive research centers dedicated to diabetes, the DRI is aggressively advancing the science needed to cure and prevent the disease. Philanthropic support from the Diabetes Research Institute Foundation (DRIF) provides critical funding that allows DRI researchers to pursue high risk, high reward projects without the common delays of traditional grant cycles.